Corpus Luteum (CL)

By RRM Academy Reviewed by Dr. Naomi Whittaker, MD, Board-Certified OBGYN, MIGS, NFPMC, FCI Updated May 13, 2026

The corpus luteum (CL) is a temporary endocrine structure that forms from the ruptured follicle after ovulation and produces the progesterone required to prepare the endometrium for implantation. It also secretes estradiol in moderate amounts. Without an adequately functioning corpus luteum, the endometrial environment cannot support implantation, and early pregnancy cannot be sustained.¹

If fertilization occurs, hCG from the implanting trophoblast binds to CL receptors and rescues the structure from its programmed regression, sustaining progesterone production until the placenta assumes that function at approximately 8 to 10 weeks of gestation.² If fertilization does not occur, the CL degenerates over 10 to 14 days, progesterone falls, and menstruation follows. The length and hormonal output of the luteal phase directly reflect corpus luteum function.

Inadequate CL function is the mechanism underlying Corpus Luteum Deficiency (CLD), a distinct subtype of luteal phase deficiency. In RRM, CL function is assessed through cycle-timed progesterone measurements in the post-peak phase. A structurally normal cycle chart with a short or inadequately supported post-peak phase is a clinical signal. The corpus luteum is not a passive structure: it reflects upstream follicular development, the hormonal environment of the cycle, and the adequacy of the LH surge. Treating CL deficiency without investigating those upstream contributors addresses the signal but not the source.

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.